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The canonical pathway of regulation of the GCK (germinal centre
kinase) III subgroup member, MST3 (mammalian Sterile20-
related kinase 3), involves a caspase-mediated cleavage between
N-terminal catalytic and C-terminal regulatory domains with
possible concurrent autophosphorylation of the activation loop
MST3(Thr178), induction of serine/threonine protein kinase
activity and nuclear localization. We identified an alternative
‘non-canonical’ pathway of MST3 activation (regulated primarily
through dephosphorylation) which may also be applicable to
other GCKIII (and GCKVI) subgroup members. In the basal
state, inactive MST3 co-immunoprecipitated with the Golgi
protein GOLGA2/gm130 (golgin A2/Golgi matrix protein 130).
Activation of MST3 by calyculin A (a protein serine/threonine
phosphatase 1/2A inhibitor) stimulated (auto)phosphorylation
of MST3(Thr178) in the catalytic domain with essentially
simultaneous cis-autophosphorylation of MST3(Thr328) in the
regulatory domain, an event also requiring the MST3(341–376)
sequence which acts as a putative docking domain. MST3(Thr178)
phosphorylation increased MST3 kinase activity, but this activity
was independent of MST3(Thr328) phosphorylation. Interestingly,
MST3(Thr328) lies immediately C-terminal to a STRAD
(Sterile20-related adaptor) pseudokinase-like site identified
recently as being involved in binding of GCKIII/GCKVI
members to MO25 scaffolding proteins. MST3(Thr178/Thr328)
phosphorylation was concurrent with dissociation of MST3 from
GOLGA2/gm130 and association of MST3 with MO25, and
MST3(Thr328) phosphorylation was necessary for formation of
the activated MST3–MO25 holocomplex.
Key words: cardiac myocyte, germinal centre kinase, mammalian
Sterile20-related kinase 3 (MST3), MO25, phosphorylation,
regulation.
INTRODUCTION
The human genome encodes 28 mammalian Ste20 (Sterile20)-
related protein kinases (so-called because of their homology
with Saccharomyces cerevisiae Ste20p or Sps1p) comprising 22
GCKs (germinal centre kinases) and six PAKs (p21-activated
kinases) [1,2]. GCKs possess an N-terminal ‘catalytic’ domain
of approximately 275 residues and a C-terminal ‘regulatory’
domain, whereas the domain order is reversed in PAKs. GCKs
are subdivided into eight subgroups (GCKI–VIII) on the basis
of sequence motifs in the regulatory domains and the identity of
a residue (cysteine, phenylalanine or tyrosine) in the P + 1 loop
of subdomain VIII. In addition, there are two STRAD (Ste20-
related adapter) ‘pseudokinases’ which are most closely related
to the GCKVI subgroup [3,4]. The GCKIII subgroup [5] is the
simplest in terms of the complexity of the regulatory domain
and comprises MST (mammalian Ste20-related protein kinase) 3
(also known as Stk24) [6], SOK1 (Ste20/oxidant stress response
kinase 1)/YSK1 (yeast Sps1/Ste20-related kinase 1; also known as
Stk25) [7,8], and MST4 [also known as MASK (MST3 and SOK1-
related kinase)] [9,10]. MST3 transcripts are most abundant in the
heart, placenta, skeletal muscle and pancreas [6], SOK1/YSK1
transcripts are most abundant in the testis (and possibly the brain)
[7,8], and MST4 transcripts are most abundant in placenta [9,10],
although all of the tested tissues probably express each GCKIII to
a degree. Interest in GCKIII members is likely to increase because
of their putative roles in pathologies such as cerebral cavernous
malformations (see [11] for a review of this disease) and those
associated with cardiac development [12].
The 431 residue MST3 ‘short’ isoform (also called MST3a
by Irwin et al. [13] to avoid confusion with the longer MST3b
isoform [14]) was first cloned from a HeLa cell library [6]. For
simplicity, we refer to this isoform as ‘MST3’. Subsequently,
brain-restricted MST3b (443 amino acid residues) was identified
[14]. As shown in Supplementary Figure S1 (at http://www.
BiochemJ.org/bj//bj4420595add.htm), there is considerable
confusion about MST3 nomenclature in the literature with the
nomenclature of the 431- and 443-residue isoforms frequently
being reversed (see [15] for a recent example). MST3b may
be identical with a protein kinase (confusingly known as
protein kinase N) first identified in 1987 [16–18]. The two
MST3 isoforms arise from translation of alternative 5′ coding
exons: exon 1 (42 nt) encodes the 14 N-terminal residues in
MST3, whereas exon 2 (78 nt) encodes the 26 N-terminal
residues in MST3b. Otherwise, the sequences of MST3 and
MST3b are identical. The 431 residue MST3 is activated by
autophosphorylation of the activation loop Thr178 [19]. MST3b
is additionally phosphorylated at Thr18 (absent from MST3)
by PKA (cAMP-dependent protein kinase) [14], but the role
of this phosphorylation in the regulation of MST3b activity is
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ambiguous. The only established MST3 ‘activator’ [6] is the PP
(protein serine/threonine phosphatase) 1/PP2A inhibitor calyculin
A [20], which presumably simply inhibits the dephosphorylation
step of a constitutively active phosphorylation/dephosphorylation
cycle. In contrast, ‘physiological regulators’ of MST3b have
been identified. In PC12 cells, MST3b is activated by nerve
growth factor or inosine and is inhibited by 6-thioguanine [13]. In
addition to its possible involvement in systemic pathologies [12],
MST3 may be involved in the regulation of cell motility [19], in
the regulation of other protein kinases [14,21–23] and caspase-
dependent [24] or -independent apoptosis [24,25]. The biological
functions of MST3b may include stimulation of axon outgrowth
[13,26], and its activation by inosine is potentially of therapeutic
benefit in restoring limb usage following cerebral focal ischaemia
(‘stroke’) [27].
Only one pathway of MST3 activation (the ‘canonical’
pathway) has thus far been characterized in detail and this is
involved in Jurkat cell apoptosis [24]. Anti-Fas antibodies or
staurosporine induce caspase-dependent cleavage of MST3 at
Asp313 at the boundary between the catalytic and regulatory
domains [24]. This reveals a bipartite NLS (nuclear localization
signal) in the C-terminus of the catalytic domain, as well as
possibly removing a nuclear export signal in the regulatory
domain [28]. Cleaved MST3 translocates into the nucleus and
is at least partly responsible for subsequent apoptosis [24,28],
although whether the cleaved MST3 is autophosphorylated and
activated seems unclear. In contrast, on the basis of incomplete
inhibition of staurosporine-induced apoptosis by the caspase
inhibitor Z-DEVD-FMK (benzyloxycarbonyl-DL-Asp-Glu-Val-
DL-Asp-fluoromethylketone), a caspase-independent involvement
of MST3 in HeLa cell apoptosis has been identified [25].
This involves loss of mitochondrial membrane potential, and
the subsequent nuclear import of apoptosis-inducing factor and
endonuclease G released from the mitochondria [25]. Although
the canonical pathway of MST3 regulation is widely accepted,
in the present paper we describe a second non-canonical pathway
of MST3 activation in cardiac myocytes which does not involve
caspase-dependent cleavage.
EXPERIMENTAL
Antibodies and proteins
Antibodies were used at a 1:1000 dilution except when stated
otherwise. Mouse mAbs (monoclonal antibodies) against human
MST3 (residues 275–393 as immunogen) were from BD
Transduction Laboratories (catalogue number 611056). A variety
of FLAG/OctA antibodies were used: rabbit polyclonal antibodies
were from Sigma–Aldrich (catalogue number F7425) or Santa
Cruz Biotechnology (catalogue number sc-807, lot K1607), and
mouse mAbs were from Santa Cruz Biotechnology (catalogue
number sc-166355). Anti-HA (haemagglutinin) antibodies (rabbit
polyclonal catalogue number sc-805, mouse mAb catalogue
number sc-7392) were from Santa Cruz Biotechnology. Mouse
monoclonal EZviewTM red anti-FLAG M2 affinity gel was from
Sigma–Aldrich (catalogue number F2426). Rabbit polyclonal
antibodies against GST (glutathione transferase) were from
Abcam (catalogue number ab9085-200). Rabbit polyclonal
antibodies against GOLGA2/gm130 (golgin A2/Golgi matrix
protein 130; catalogue number 11308-1-AP) and CCM3/PDCD10
(cerebral cavernous malformation 3/programmed cell death
10; catalogue number 10294-2-AP) were from Proteintech
Group. Rabbit mAbs against MO25α (catalogue number 2716)
and antibodies against cleaved (activated) caspase 3(Asp175)
(catalogue number 9661) were from Cell Signaling Technology.
Sheep polyclonal antibodies against MO25β were gifts from
Professor Dario Alessi and Dr Paola de los Heros (MRC Protein
Phosphorylation Unit, University of Dundee, Dundee, U.K.) and
were used at a 1:400 dilution.
Horseradish peroxidase-conjugated anti-mouse (catalogue
number P0260) and anti-rabbit (catalogue number P0448)
secondary antibodies were from Dako, and Pierce horseradish
peroxidase-conjugated anti-sheep antibodies were from Ther-
moFisher (catalogue number 31627). The Alexa Fluor® 488-
conjugated anti-mouse secondary antibody (catalogue number
A11001) and Texas Red–phalloidin (catalogue number T7471)
were from Invitrogen.
The catalytic domain of human recombinant PP2A was from
Cayman Chemicals (catalogue number CAY10011237) and was
obtained via Cambridge Bioscience. MBP (myelin basic protein)
was from Millipore (catalogue number 13-104).
Cardiac myocyte isolation and culture
Rats were housed and work was under taken in accordance
with the local institutional animal care committee and the U.K.
Animals (Scientific Procedures) Act 1986. Primary cultures of
ventricular cardiac myocytes were prepared from 1–2-day-old
Sprague–Dawley rats by collagenase and pancreatin digestion of
ventricles using an adaptation of the method of Iwaki et al. [29] as
described recently in detail [30]. Except for immunofluorescent
staining experiments, cardiac myocytes were plated on gelatin-
precoated PrimariaTM surface-modified polystyrene culture dishes
[BD Biosciences, catalogue numbers 353801 (35 mm) and
353802 (60 mm)] at densities of 2×106 myocytes per 35 mm
dish or 4×106 myocytes per 60 mm dish. After 18 h, myocytes
were confluent and beating spontaneously. Unless they were
to be infected with AdV (adenoviral) vectors, serum was then
withdrawn and myocytes were incubated in maintenance medium
{Dulbecco’s modified Eagle’s medium/medium 199 [4:1 (v/v)]
and penicillin and streptomycin (100 units/ml for each)} for
a further 24 h. For AdV infection, serum was withdrawn 6 h
beforehand and the infected myocytes were used within 48 h.
MST3 cloning and AdV vector preparation
The MST3 coding sequence was amplified from neonatal rat
cardiac myocyte cDNA with Pfu polymerase using the forward
primer 5′-GACGACAAGGGTACCATGGCCCACTCCCCGGT-
GCAG-3′ and the reverse primer 5′-CTTATCTAGAAGCTT-
TCAGTGCGCTGAGGCTCCTCCA-3′ to produce a MST3
product (containing the initiator methionine residue) flanked
by the KpnI and HindIII sites (underlined). These restriction
sites were then used for insertion into the corresponding sites
in FLAG-pShuttle-CMV [31]. The product was sequenced and
submitted to GenBank® (accession number EU371958.1). MST3
C-terminal deletion mutants were constructed similarly, but using
the reverse primers 5′-CTTATCTAGAAGCTTTCAATCTGTCT-
CCACATCTGA-3′ [for MST3(314–431)], 5′-CTTATCTAG-
AAGCTTTCATCCGTTCTCCAGATTCTTGG-3′ [for MST3
(341–431)] and 5′-CTTATCTAGAAGCTTTCATTTCAGCTC-
CGCAAACAGAG-3′ [for MST3(377–431)]. Point mutations
were introduced into MST3 by PCR using forward and reverse
complementary primer pairs that contained the desired base
change(s) flanked by 15 bases on either side. Two separate PCR
amplifications were performed using the pShuttle-CMV forward
primer (5′-GGTCTATATAAGCAGAGCTG-3′) in combination
with the MST3 mutant reverse primer and the pShuttle-CMV
reverse primer (5′-GTGGTATGGCTGATTATGATCAG-3′) in
combination with the mutant MST3 forward primer, with wild-
type MST3 as a template. Subsequently, a third PCR was
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performed using pShuttle-CMV forward and reverse primers and a
mixture of the two purified mutant products from the first round of
PCRs. The mutant PCR product generated was purified and cloned
into the Kpn1 and HindIII sites of FLAG-pShuttle-CMV. Where
multiple mutations were required, they were introduced together
on the same primer pair if close together or, if further apart,
were introduced sequentially. All constructs were sequenced to
verify that the desired mutation(s) was present and that no further
mutations had been introduced during the PCR procedure. AdVs
were generated from the shuttle plasmids using the AdEasyTM XL
Adenoviral Vector System (Stratagene), as described previously
[30,31].
Immunoblotting
Following treatments, myocytes were washed twice with ice-
cold PBS and scraped into Buffer A [20 mM 2-glycerophosphate
(pH 7.5), 50 mM NaF, 5 mM dithiothreitol, 2 mM EDTA, 0.2 mM
Na3VO4, 2 μM microcystin LR and 1% (v/v) Triton X-100]
containing protease inhibitors {10 mM benzamidine, 300 μM
PMSF, 200 μM leupeptin and 10 μM E-64 [trans-epoxysuccinyl-
L-leucylamido-(4-guanidino)butane]} (100 μl per 35 mm dish
and 150 μl per 60 mm dish). Samples were incubated on ice
for 10 min and then centrifuged (10000 g for 5 min at 4 ◦C).
Supernatants were denatured by heating at 100 ◦C with 0.33
vol. of 4× SDS/PAGE sample buffer as described previously
[30]. Non-specific binding sites were blocked with 5% (w/v)
non-fat milk powder in TBST [Tris-buffered saline plus Tween
20; 20 mM Tris/HCl (pH 7.5), 137 mM NaCl and 0.1% Tween
20] for 30 min. Blots were incubated with primary antibodies in
TBST containing 5% (w/v) BSA overnight at 4 ◦C. The blots were
washed three times with TBST [for 5 min at room temperature
(21 ◦C)], incubated with secondary antibodies [1:5000 dilution
in TBST containing 1% (w/v) non-fat milk powder for 1 h at
room temperature] and then washed again three times with TBST
(for 5 min at room temperature). Bands were detected by ECL
(enhanced chemiluminescence; Santa Cruz Biotechnology) using
Hyperfilm MP and were quantified by scanning densitometry.
Latterly, bands were detected with GE Healthcare ECL Plus
and a GE ImageQuant 350 imager with one-dimensional gel
analysis software. Unless divided by a vertical bar, all individual
immunoblots shown are images of single gels, although the lane
order has been altered by image manipulation in some cases to
improve comprehensibility.
Immunoprecipitations and immunokinase assays
Myocytes were washed twice with ice-cold PBS and extracted into
Buffer B [20 mM Tris/HCl (pH 7.5), 300 mM KCl, 5 mM MgCl2,
5 mM NaF, 1 mM EDTA, 0.2 mM Na3VO4, 2 μM microcystin
LR, 10% (v/v) glycerol, 1% (v/v) Triton X-100 and 0.05% 2-
mercaptoethanol containing the protease inhibitors as for Buffer
A]. When myocytes had been pre-exposed to 100 nM calyculin A,
calyculin A (100 nM) was also included in the extraction buffer.
Samples were incubated on ice for 10 min and then centrifuged
(10000 g for 5 min at 4 ◦C). The supernatants were retained and
samples were taken for immunoblotting to assess the input of the
proteins subsequently immunoprecipitated. For immunokinase
assays, supernatants (27.5 μl) were diluted to 150 μl with Buffer
B and added to 15 μl of EZviewTM red anti-FLAG M2 affinity
gel (1:1 slurry in Buffer B), followed by overnight incubation at
4 ◦C with rotation. The pellets were collected by centrifugation
(10000 g for 1 min at 4 ◦C) and washed three times in Buffer B
(0.7 ml), once with kinase assay buffer [20 mM Tris/HCl (pH 7.5),
1 mM dithiothreitol, 1 μM microcystin LR, 4 μM leupeptin and
1 mM benzamidine; 150 μl) and finally resuspended in 45 μl of
kinase assay buffer containing 0.5 mg/ml MBP and 1 μM PKA
inhibitor (TTYADFIASGRTGRRNAIHD; Bachem).
FLAG–MST3 immunokinase assays were initiated by the
addition of 5 μl of 1 mM [γ -32P]ATP (0.5 μCi/assay)/200 mM
MgCl2 followed by incubation at 30 ◦C for 30 min. Reactions
were terminated by the addition of 5 μl of 0.5 M EDTA (pH 7.5),
followed by cooling on ice. Samples were centrifuged (10000 g
for 1 min at 4 ◦C) and duplicate samples (20 μl) of supernatants
were spotted on to Whatman P81 paper squares, which were
then washed four times in 75 mM H3PO4 (for 15 min) on a
rocking platform. Radioactivity was measured by ˇCerenkov
radiation counting. Blanks (one with kinase assay buffer and
[γ -32P]ATP/MgCl2, and one involving the assay of MBP kinase
activity with immunoprecipitates from uninfected myocytes) were
routinely included.
Dephosphorylations with PP2A
FLAG–MST3 in samples taken from pooled extracts of
myocytes which had or had not been exposed to 100 nM
calyculin A for 10 min was prepared essentially as described
in the Immunoprecipitations and immunokinase assays section.
Immunoprecipitates were washed three times with Buffer C
[50mM Tris/HCl (pH 7.0), 0.15 mM EGTA, 0.1% 2-mercapto-
ethanol and 0.1% BSA] and resuspended in 25 μl of
Buffer C. GST–MST3 was similarly precipitated using
glutathione–Sepharose. Dephosphorylation was then initiated by
the addition of PP2A (25 μl, 10 units/μl in Buffer C) in the
absence or presence of 2 μM okadaic acid. Incubations were
for up to 30 min at 30 ◦C, and PP2A activity was terminated
by the addition of 0.1 vol. of 50 μM okadaic acid/2 μM calyculin
A. Immunoprecipitates were washed with Buffer C, centrifuged
(10000 g for 5 min at 4 ◦C) and the pellets extracted into 50 μl of
2× sample buffer for subsequent immunoblotting.
Gel filtration
Supernatants (prepared in Buffer B from 60 mm dishes of
monocytes as described in the Immunoblotting section) of AdV–
MST3-infected myocytes were applied to columns of Sephacryl
S200HR (1.4 cm×85 cm, 131 ml inclusion volume measured
using 3H2O) or Sephacryl S300HR (1.6 cm×95 cm, 185 ml
inclusion volume) equilibrated with 50 mM Tris/HCl (pH 7.5),
250 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol and 0.03%
Brij-35 which had been standardized with proteins of known
Stokes’ radii. When extracts of calyculin A-treated myocytes
were examined, the elution buffer additionally contained 50 nM
calyculin A. Flow rates were 0.2–0.3 ml/min and fractions of 0.6–
1.3 ml as required were collected. In some cases, fractions were
centrifugally concentrated at 4 ◦C by up to 10–15-fold in Amicon
Ultra-2 10 kDa nominal molecular mass limit centrifugal filter
devices (Millipore).
Immunocytochemistry
Myocytes (1.5×106 cells per 35 mm Primaria culture dish) were
cultured on to glass coverslips precoated with 1% (w/v) gelatin
followed by laminin (20 μg/ml in PBS). Myocytes were cultured
as described in the Cardiac myocyte isolation and culture section,
and were infected with AdV–FLAG–MST3 for 16 h in serum-
free medium. After treatment, myocytes were washed with ice-
cold PBS (3×0.5 ml), fixed in 4% (v/v) formaldehyde (10 min
at room temperature), permeabilized with 0.1% Triton X-100
in PBS (10 min at room temperature) and incubated with 1%
(w/v) BSA in PBS containing 0.1% Triton X-100 (10 min
at room temperature) to block non-specific antibody binding.
FLAG–MST3 was detected by incubation of cells with Santa
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Cruz Biotechnology mouse anti-FLAG mAbs (1:1000 dilution
for 1 h at 37 ◦C), then incubated with goat anti-(mouse IgG)
coupled to Alexa Fluor® 488 (1:200 dilution for 1 h at 37 ◦C)
followed by Texas Red®-X phalloidin (Invitrogen; 1:200 dilution
for 1 h at 37 ◦C). Nuclei were stained with Hoechst 33258
(Sigma; 10 μg/ml for 15 min at 37 ◦C). Coverslips were washed
with PBS (3×0.5 ml) between each incubation, mounted with
fluorescence mounting medium (Dako), viewed under a Zeiss
Axioskop fluorescence microscope with a ×40 objective, and
photographed using a digital camera.
Structural studies
The disorder probability plot was produced using the DISOclust
method (http://www.reading.ac.uk/bioinf/DISOclust/) for the
prediction of intrinsically unstructured regions in proteins [32].
Predicted secondary structure was obtained using the PSIPRED
server (http://bioinf.cs.ucl.ac.uk/psipred/) [33]. The three-dimen-
sional model was produced using the IntFOLD-TS method
(http://www.reading.ac.uk/bioinf/IntFOLD/) [34,35] and was
colour coded from blue (high accuracy) through green, yellow
and orange to red (low accuracy) using the ModFOLDclust2
model quality assessment method (http://www.reading.ac.uk/
bioinf/ModFOLD/) [36]. The image was rendered using PyMol
(http://www.pymol.org). Protein sequences were taken from
the NCBI (National Center for Biotechnology Information)
protein database (http://www.ncbi.nlm.nih.gov/protein/). Align-
ments were carried out using ClustalW2 (http://www.ebi.ac.
uk/Tools/msa/clustalw2/) with manual curation if necessary.
RESULTS AND DISCUSSION
Primary sequence of rat MST3
We cloned and sequenced rat MST3 (GenBank® accession
number EU371958.1, submitted 23 January 2008). The
predicted 431 residue sequence (Supplementary Figure S1)
has 98.6% and 96.8% identity with the (431 residue) MST3
of mouse (GenBank® accession number NP_663440.1) and
Homo sapiens (GenBank® accession number NP_001027467.2;
cloned by Schinkmann and Blenis [6]) respectively, with mostly
conservative or semi-conservative substitutions elsewhere. The
ATP-binding site [GXGXXGX(14–23)K] in rat MST3 lies between
residues 31 and 53, the activation loop serine/threonine is Thr178,
and the ‘caspase cleavage’ site is V310ETD313 (AETD in H.
sapiens). The residue in the 314 position is glycine in H. sapiens
and mouse, but is serine in rat. Thus, although Gly314 has
been identified as a possible N-myristoylation site that becomes
available following caspase cleavage of MST3 [37,38], this cannot
occur in the rat and N-myristoylation of MST3(314–431) may not
be of universal importance.
Phosphorylation of MST3 in cardiac myocytes
MST3(275–393) mAbs detected MST3 as a single band of
∼52 kDa in cardiac myocyte extracts, and exposure of myocytes
to calyculin A (100–200 nM) resulted in its rapid (complete
in <10 min) loss (Figure 1A). To investigate this further, N-
terminally FLAG-tagged rat full-length (431 residue) MST3
[FLAG–MST3(FL)] was expressed in cardiac myocytes using
an AdV vector. In unstimulated myocytes, FLAG–MST3(FL)
was detected as a band of ∼54 kDa with anti-MST3(275–393)
mAbs which predominated over endogenous MST3 (Figure 1B,
upper panel). Exposure of myocytes to 100 nM calyculin A
resulted in the loss of both endogenous MST3 and FLAG–
MST3(FL) (Figure 1B, upper panel). Immunoblotting with
anti-FLAG antibodies revealed that FLAG–MST3(FL) was not
lost following calyculin A exposure, but instead migrated at
∼58 kDa (Figure 1B, lower panel). Loss of the 54 kDa band
and appearance of 58 kDa FLAG–MST3(FL) were essentially
complete by 5–10 min (Figure 1B, lower panel), and there
were no increases in bands of <58 kDa (Supplementary
Figure S2 at http://www.BiochemJ.org/bj/bj4420595add.htm)
indicating absence of detectable cleavage. The broad-spectrum
serine/threonine protein kinase inhibitor staurosporine reduced
the rate of the appearance of 58 kDa FLAG–MST3(FL) in ca-
lyculin A-treated myocytes (Figure 1C), suggesting that the band
shift represents serine/threonine phosphorylation. Additional
evidence that the 58 kDa band resulted from phosphorylation was
obtained using phos-tagTM SDS/PAGE immunoblots [39]. Anti-
FLAG antibodies detected multiple FLAG–MST3(FL) bands even
in unstimulated myocytes (Figure 1D, left-hand panel). Following
exposure of myocytes to calyculin A, the overall mobility of
the bands was reduced, indicating that FLAG–MST3(FL) was
increasingly phosphorylated. A ‘control’ SDS/PAGE immunoblot
from the same experiment is shown for comparison (Figure 1D,
right-hand panel).
We confirmed that serine/threonine phosphorylation of FLAG–
MST3(FL) caused the shift from 54 kDa to 58 kDa (Figure 1B,
lower panel) by treating FLAG–MST3(FL) immunoprecipitates
from calyculin A-treated myocytes with recombinant PP2A. This
resulted in the disappearance of the 58 kDa FLAG–MST3 band
with the reappearance of the 54 kDa band (Figure 1E). This was
prevented by inclusion of the PP1/PP2A inhibitor okadaic acid
in the PP2A incubation (Figure 1F), indicating that proteolysis,
for example, was not responsible. Furthermore, in glutathione–
Sepharose precipitates of myocytes expressing GST–MST3(FL)
which had been exposed to calyculin A, the band detected by
anti-MST3(275–393) mAbs reappeared with PP2A treatment
detected using anti-GST antibodies (Figure 1G, upper panel)
with simultaneous reappearance of the more rapidly migrating
dephosphorylated band (Figure 1G, lower panel). Analogous
experiments using phos-tagTM SDS/PAGE gels and anti-FLAG
antibodies confirmed that FLAG–MST3(FL) reverted to the more
rapidly migrating forms and this was prevented by okadaic acid
(Figure 1H). However, even in PP2A-treated immunoprecipitates,
multiple FLAG–MST3 bands remained clearly visible in phos-
tagTM SDS/PAGE gels (Figure 1H). We interpret this as indicating
that either residues other than serine/threonine (e.g. tyrosine)
are phosphorylated or that MST3 contains phosphorylated
serine/threonine residues that are resistant to PP2A. There are
at least two precedents for the latter interpretation [40,41].
The only other agent that resulted in the appearance of the
58 kDa FLAG–MST3 in cardiac myocytes was okadaic acid
(results not shown). A very recent paper [15] has also shown
that okadaic acid reduced the mobility of endogenous MST3
in HEK (human embryonic kidney)-293 cells [detected using
mAbs to an epitope in the C-terminus of MST3(FL)], which
was reversed by incubation with exogenous purified PP2A.
The list of agonists/stimuli that do not activate (i.e. reduce
the mobility to 58 kDa, as explained below) MST3 includes
Gq-protein-coupled receptor agonists (e.g. endothelin-1 and α-
adrenergic agonists), Gs-protein-coupled receptor agonists (e.g.
isoprenaline), peptide growth factors (e.g. epidermal growth factor
and insulin) and stress stimuli such as tunicamycin (to induce
endoplasmic reticulum stress), hyperosmotic shock and oxidative
stress (results not shown).
In summary, we conclude that exposure of myocytes
to calyculin A induces serine/threonine phosphorylation of
MST3(FL). Because anti-MST3(275–393) mAbs fail to recognize
FLAG–MST3(FL) following calyculin A exposure (Figure 1B,
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Figure 1 Phosphorylation of MST3 and FLAG–MST3(FL) species
Myocytes were uninfected (A), infected with AdV–FLAG–MST3(FL) (B–F and H) or infected with AdV–GST–MST3(FL) (G). They were exposed to 100 nM calyculin A for the times indicated
and extracts were prepared. Proteins were separated by SDS/PAGE (A–C) or (E–G) phos-tagTM SDS/PAGE (D and H) followed by immunoblot (IB) analysis. (A) Extracts were immunoblotted
with anti-MST3(275–393) mAbs and the bands (left-hand panel) were quantified (right-hand panel). (B) Extracts were immunoblotted with anti-MST3(275–393) mAbs (upper panel) to detect
endogenous MST3 and FLAG–MST3(FL) or with anti–FLAG antibodies (Abs, lower panel) to detect FLAG-MST3(FL). (C) Myocytes were unstimulated, or exposed to calyculin A in the absence or
presence of staurosporine (1 μM) and extracts were immunoblotted with anti-FLAG antibodies. (D) Extracts were analysed using phos-tagTM SDS/PAGE (left-hand panel) or SDS/PAGE (right-hand
panel) and immunoblotted with anti-FLAG antibodies. (E–H) Myocytes expressing FLAG–MST3(FL) (E, F and H) or GST–MST3(FL) (G) were unstimulated or exposed to calyculin A for 10 min.
FLAG–MST3(FL) was immunoprecipitated using anti-FLAG M2 affinity gel and GST–MST3(FL) was precipitated using glutathione–Sepharose. Precipitates were incubated with PP2A for the times
indicated. In some instances (F and H), 2 μM okadaic acid was included in the PP2A incubations. Extracts were immunoblotted with anti-FLAG (E, F and H), anti–MST3(275–393) mAbs (G, upper
panel), or anti-GST antibodies (G, lower panel). (E) The lanes showing extracts of myocytes exposed to calyculin A (upper panel) were quantified (lower panel). , upper band; , lower band.
Experiments were repeated at least twice with similar results with different myocyte preparations.
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Figure 2 Identification of a novel phosphorylation site (Thr328) in MST3
Myocytes were infected with the appropriate AdV vectors. Myocytes expressing FLAG–MST3(FL), MST3 truncation mutants [FLAG–MST3(314–431), FLAG–MST3(341–431) or
FLAG–MST3(377–431)] or MST3 with alanine substitutions [FLAG–MST3(4A) with S317A, S320A, S322A and T328A mutations or FLAG–MST3(S317A), FLAG–MST3(S320A),
FLAG–MST3(S322A); FLAG–MST3(T328A)] were unstimulated (A–E) or exposed to calyculin A (100 nM for 10 min) (A and C–E) and extracts prepared. Proteins were separated by SDS/PAGE
followed by immunoblot (IB) analysis with anti-FLAG antibodies (Abs) (A) (B and C, left-hand panels) and (E) or anti-MST3(275–393) mAbs (B and C, right-hand panels) and (D). Experiments were
repeated at least twice with different myocyte preparations with similar results.
upper panel), the phosphorylation site(s) probably lies between
residues 275 and 393 and is distinct from the previously identified
phosphorylation of MST3 on Thr178 of its activation loop [19].
Identification of a novel phosphorylation site in MST3
To identify the potential phosphorylation site(s) additional to
MST3(Thr178) deletion mutants were generated and expressed
in myocytes: FLAG–MST3(314–431) with deletion of Ser314–
His431, FLAG–MST3(341–431) with deletion of Thr341–His431
and FLAG–MST3(377–431) with deletion of Glu377–His431.
Incubation of myocytes with calyculin A reduced the mobility of
FLAG–MST3(FL) or FLAG–MST3(377–431) on SDS/PAGE,
but not that of FLAG–MST3(314–431) or MST3(341–431)
(Figure 2A). Thus the site(s) of phosphorylation responsible for
reduced migration probably lies between Ser314 and Lys376. In
addition, although the anti-MST3(275–393) mAbs recognized
FLAG–MST3(FL) and MST3(341–431), they did not recognize
FLAG–MST3(314–431) (Figure 2B). This suggests that the
epitope recognized by the MST3(275–393) mAbs probably lies
between Ser314 and Gly340.
We used alanine scanning to identify the phosphorylation
site on MST3, focusing first on the Thr341–Lys376 region
because of the differing behaviour of FLAG–MST3(314–
431) and FLAG–MST3(341–431) to FLAG–MST3(377–431)
following calyculin A exposure (Figure 2A). In this regard,
a proteomics study had shown that MST3(Thr341) was
phosphorylated in a lymphoma cell line [42]. All six
serine/threonine residues in the Thr341–Lys376 region of FLAG–
MST3(FL) were mutated to alanine either individually or all
together, and the proteins expressed in myocytes. On SDS/PAGE,
the mobilities of all seven mutants were still reduced to 58 kDa by
calyculin A (Supplementary Figure S3A at http://www.BiochemJ.
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org/bj/bj4420595add.htm). Thus, although the MST3(341–376)
region is required for the phosphorylation(s) resulting in reduced
mobility on SDS/PAGE (Figure 2A), it does not contain the
phosphorylation site(s) and presumably represents a docking
domain. We next examined the Ser314–Gly340 region. We had
separately examined FLAG–MST3(S314G) earlier because of the
difference at residue 314 between rat (serine) and H. sapiens
or mouse (glycine; Supplementary Figure S1), and found that
its migration was reduced to the same extent by exposure to
calyculin A as that of FLAG–MST3(FL) (results not shown). The
appearance of 58 kDa FLAG–MST3 when Ser317, Ser320, Ser322
and Thr328 were all mutated to alanine [FLAG–MST3(4A)] was
not reduced to the same extent as FLAG–MST(FL), although
a slight reduction was apparent (Figure 2C, left-hand panel).
Furthermore, anti–MST3(275–393) mAbs failed to recognize
FLAG–MST3(4A) with or without exposure of myocytes to
calyculin A (Figure 2C, right-hand panel). With individual single
alanine substitutions, although FLAG–MST3(T328A) remained
detectable using FLAG antibodies, this mutation alone caused
the loss of the anti–MST3(275–393) mAb epitope even in the
absence of exposure to calyculin A (Figure 2D), and the finding
that the mobility of FLAG–MST3(T328A) was not reduced
to the same extent as FLAG–MST3(FL) by calyculin A
indicated that phosphorylation of FLAG–MST3(Thr328) was
responsible for the major reduction in FLAG–MST3(FL) mobility
(Figure 2E). The mobility of FLAG–MST3(T328A) was still
slightly reduced in myocytes exposed to calyculin A, presumably
resulting from phosphorylation of another residue [potentially
FLAG-MST3(Thr178)]. It is noteworthy that endogenous MST3
was still detectable by anti-MST3(275–393) mAbs in FLAG–
MST3(T328A)-infected myocytes that had not been exposed to
calyculin A (fourth lane from the right-hand side of Figure 2D),
showing that the failure of these mAbs to recognize FLAG–
MST3(T328A) did not result from technical problems.
PhosphSitePlus® (http://www.phosphosite.org) lists a fur-
ther four potentially phosphorylatable serine residues in
the MST3(275–393) region (A296EQpSHDDpSpSpSEDSDAE-
TDGQASGGSDSGDWIFTIR330; where pS represents potentially
phosphorylatable serine residues) identified by proteomics
approaches [43,44]. (Readers should rely on sequence information
rather than numerical annotation because of the confusion
in MST3(a)/MST3b terminology.) However, serine-to-alanine
mutation of each of these serine residues (Ser299, Ser303, Ser304
and Ser305) and Ser308 in addition, or mutation of all residues in
FLAG–MST3 produced proteins that were indistinguishable from
FLAG – MST3 (FL) in response to calyculin A (Supplementary
Figure S3B). Our overall conclusions from the experiments
shown in Figure 2 are as follows. First, that the MST3(341–376)
region is required for the reduced migration of FLAG–MST3(FL)
resulting from its phosphorylation, but that this region does
not contain the phosphorylation site responsible for the reduced
migration. Secondly, cis-autophosphorylation of MST3(Thr328)
is responsible for the greater proportion of the calyculin A-
induced reduction in FLAG–MST3(FL) migration. Thirdly, the
identity and the phosphorylation of MST3(Thr328) is crucial for
the recognition of MST3 by anti-MST3(275–393) mAbs.
Regulation of MST3 kinase activity
We next examined the relative mobilities of FLAG–MST3(FL)
containing mutations in or close to the activation loop
by SDS/PAGE. Mutation of the activation loop Thr178
phosphorylation site [FLAG–MST3(T178A)] prevented the
appearance of any 58 kDa FLAG–MST3 band following exposure
of myocytes to calyculin A (Figure 3A, left-hand panel) and
Figure 3 Phosphorylation of MST3(Thr178), but not MST3(Thr328), is
required for MST3 activity
Myocytes were infected with the appropriate AdV vectors. Myocytes express-
ing FLAG–MST3(FL), FLAG–MST3(T178A), FLAG–MST3(T178D), FLAG–MST3(K53R),
FLAG–MST3(314–431) or FLAG–MST3(T328A) were unstimulated or exposed to calyculin A
(100 nM for 10 min) and extracts were prepared. Proteins were separated by SDS/PAGE (A,C and
D) or phos-tagTM SDS/PAGE (B) followed by immunoblot (IB) analysis with anti-FLAG antibodies
(Abs) (A, left-hand panel), (B and C, left-hand three panels) and (D), or anti–MST3(275–393)
mAbs (A and C, right-hand panels). Immunoblots are representative of experiments repeated at
least twice with different myocyte preparations. (D) Immunokinase assays of FLAG–MST3(FL)
and FLAG–MST3 mutants. Myocytes were unstimulated (open columns) or exposed to calyculin
A (100 nM for 10 min; filled columns). Incorporation of 32P from [γ -32P]ATP into MBP was
measured and the results from a single experiment are shown. Values above the columns
(means +− S.E.M.; n = 3 separate preparations of myocytes) are the ratios of kinase activities
(c.p.m. incorporated/30 min of incubation) in myocytes in the absence or presence of calyculin
A. The panels above the histogram are immunoblots with anti-FLAG antibodies of extracts of
myocytes expressing the various FLAG–MST3 species demonstrating that similar quantities of
FLAG–MST3 were used in the immunokinase assays.
the anti-MST3(275–393) mAb epitope was also preserved
(Figure 3A, right panel). Phos-tagTM/SDS gels (Figure 3B)
confirmed the result shown in the left-hand panel of Figure 3(A).
Thus phosphorylation of MST3(Thr328) requires MST3 kinase
activity and the data suggest that this autophosphorylation occurs
in cis rather than in trans (since endogenous MST3 would
have been activated by calyculin A in these experiments).
GCKs reportedly possess a ‘secondary’ phosphorylation site
lying in the conserved GTP(C,F,Y)WMAPE sequence in the
P + 1 loop (Thr182 in MST3), phosphorylation of which may
be required for activation [2]. Phosphorylation of this residue
has been detected experimentally by proteomics approaches
[44,45], but care must be taken in annotation because of sequence
similarities between GCKIII members in this region. Compared
with FLAG–MST3(FL) (Figure 3A), there was only a partial
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shift of FLAG–MST3(T182A) to a lower mobility species in
myocytes exposed to calyculin A (Figure 3C), possibly indicating
a requirement of MST3(Thr182) phosphorylation for MST3
activation as assessed by MST3(Thr328) cis-autophosphorylation.
However, the analogous threonine residue in the catalytic subunit
of PKA is important in the kinase–protein substrate interaction
[46], and this is also true for other protein serine/threonine
kinases. Thus it is equally likely that the FLAG–MST3(T182A)
mutation reduces the affinity of MST3 for its substrates, in
this case, FLAG–MST3(Thr328). Gordon et al. [15] recently
obtained similar results to those of the present study using FLAG–
MST(T178A) and FLAG–MST3(T182A). They also studied the
FLAG–MST3(T172A) mutation since MST3(phosphoThr172) has
also been detected by proteomics approaches [44,47,48]. The
mobility of FLAG–MST3(T172A) was still reduced by okadaic
acid [15], and the conclusion was that phosphorylation of this site
is unimportant in the appearance of 58 kDa FLAG–MST3(FL)
[15].
The phosphomimetic mutation, FLAG–MST3(T178D), res-
ulted in the constitutive appearance of 58 kDa FLAG–
MST3(T178D), suggesting stimulation of cis-autokinase activity,
though 54 kDa FLAG–MST3(T178D) was never completely lost
(Figure 3C). Calyculin A did not cause a complete shift of FLAG–
MST3(T178D) to the 58 kDa band (Figure 3C), although there
may have been an increase in the relative abundance of 58 kDa
FLAG–MST3(T178D) species following exposure of myocytes
to calyculin A compared with untreated myocytes (Figure 3C),
which presumably results from increased preservation of FLAG–
MST3(Thr328) phosphorylation. Mutation of the essential Lys53
in the MST3 ATP-binding site to an arginine residue [FLAG–
MST3(K53R)] prevented the appearance of any 58 kDa
FLAG–MST3 on exposure of myocytes to calyculin A and the
MST3(275–393) mAb epitope was preserved (Figure 3C).
In vitro immunokinase activities of the various MST3 mutants
were assessed by phosphorylation of MBP. Myocytes were
infected with AdV–FLAG–MST3 constructs titrated to produce
essentially equal expression of FLAG–MST3 species (Figure 3D).
MST3 is reportedly more active in such assays with Mn2 +
rather than with Mg2 + as the metal ion cofactor, although the
relative magnitude varies with metal ion concentration [6,19,49].
In our assays, FLAG–MST3(FL) was only ∼30% as active with
20 mM Mn2 + in untreated or calyculin A-treated myocytes as with
20 mM Mg2 + (results not shown), thus Mg2 + was routinely used.
Activities of FLAG–MST3(FL), FLAG–MST3(314–431) and
FLAG-MST3(T328A) were stimulated to a similar overall level
by calyculin A (Figure 3D), suggesting that FLAG–MST3(Thr328)
phosphorylation does not play any direct role in the regulation
of MST3 activity. Furthermore, the fact that activity of FLAG–
MST3(1–313) was indistinguishable from FLAG–MST3(FL)
(Figure 3D) confirms that phosphorylation of MST3(Thr178) in
the catalytic domain did not contribute significantly to the reduced
migration of FLAG–MST3(FL). Because FLAG–MST3(314–
431) was not constitutively active, the concept that caspase
cleavage of MST3 results in constitutive activation [24,28]
could not be confirmed in our system. FLAG–MST3(341–
431) and FLAG–MST3(377–431) were activated similarly to
FLAG–MST3(314–431) and FLAG–MST3(FL) (results not
shown). As expected, FLAG–MST3(T178A) exhibited a very
low level of relative activation by calyculin A (Figure 3D)
and FLAG–MST3(K53R) was completely inactive (results
not shown), consistent with the findings of Lu et al. [19].
FLAG–MST3(T178D) may be slightly more active in the
absence of calyculin A exposure than FLAG-MST3(FL) and,
as expected, was only very slightly activated by calyculin
A. Our general conclusion is that the activation of FLAG–
MST3(FL) and the appearance of the FLAG–MST3 [i.e.
FLAG–MST3(phosphoThr178/phosphoThr328)] band at 58 kDa are
different aspects of the same process.
Although we have concluded that the phosphorylation of
MST3(Thr328) represents a cis-autophosphorylation, the kinase(s)
responsible for phosphorylation of MST3(Thr178) is unclear.
Previous work suggests that the MST3(Thr178) phosphorylation
is also an autophosphorylation [6,19]. FLAG–MST3(T178A)
expresses a very low, but detectable, MBP kinase activity
(Figure 3D), whereas in contrast FLAG–MST3(K53R) is com-
pletely inactive (results not shown). Hence autophosphorylation
of MST3(Thr178) could lead to rapid autocatalytic activation
following PP1/PP2A inhibition. In addition, we examined
the rat MST3 primary sequence (Supplementary Figure S1)
with Scansite (http://scansite.mit.edu). At medium stringency,
Scansite identified PKA as a putative MST3(Thr178) kinase.
However, isoprenaline did not cause any reduction in mobility
in FLAG–MST3(FL) on SDS/PAGE that should result from
MST3(Thr178) phosphorylation and subsequent MST3(Thr328) cis-
autophosphorylation (results not shown). At high stringency,
MST3(Ser305) was identified as a putative casein kinase 2 site.
Although it is possible that this site is phosphorylated, its
phosphorylation does not contribute to the reduction in mobility
seen with calyculin A (Supplementary Figure S3B).
Lu et al. [19] identified two tryptic phosphopeptides in
autophosphorylated recombinant MST3(FL), one of which
contained phosphoThr178 that was responsible for autoactivation.
The second tryptic phosphopeptide was not identified and could
contain MST3(phosphoThr328). We did not detect ‘constitutive’
autophosphorylation (Figure 1B, lower panel) or autoactivation
(Figure 3D) of FLAG–MT3(FL) in myocytes in the absence
of calyculin A. However, immunoblots in the study by Lu
et al. [19] of immunoprecipitated HA–MST3(FL) expressed in
COS-1 cells [with antibodies against residues 310–432 (sic)]
detected two bands. These were identified as ‘unphosphorylated’
HA–MST3(FL) and autophosphorylated HA–MST3(FL). but,
from the extent of the reduction in mobility, the latter may
represent HA–MST3(phosphoThr178/phosphoThr328) rather than
HA–MST3(phosphoThr178).
Canonical pathway of activation of MST3 in cardiac myocytes
Others have shown that MST3 is cleaved immediately C-terminal
to Asp313 by caspases during apoptosis, generating a species that
translocates to the nucleus [24,28]. The anthracycline daunomycin
stimulates apoptosis and caspase activation in cardiac myocytes
[50–52], thus we examined its effects on cleavage of FLAG–
MST3(FL). As expected, daunomycin increased the appearance
of the active 17 kDa fragment of caspase 3 in uninfected
cardiac myocytes or myocytes expressing FLAG–MST3(FL),
confirming stimulation of apoptosis (Figure 4A). There was
detectable cleavage of FLAG–MST3(FL) to a form that co-
migrated with FLAG–MST3(314–431) (Figure 4B), indicating
that induction of apoptosis resulted in MST3 cleavage. However,
there was no detectable loss of the endogenous immunosignal
detected by MST3(275–393) mAbs [which do not recognize
FLAG–MST3(314–431); Figure 2B] in uninfected myocytes
(Figure 4C). We also examined the subcellular localization
of FLAG–MST3(FL) following activation by calyculin A and
of FLAG–MST3(314–431). In unstimulated cells, FLAG–
MST3(FL) was mainly cytoplasmic [Figure 4D(i)], whereas
FLAG–MST3(314–431) constitutively accumulated in the
nucleus [Figure 4D(ii)] even though it cannot be enzymically
active (Figure 3D). No significant accumulation of FLAG–
MST3(FL) in the nucleus was detected following exposure to
c© The Authors Journal compilation c© 2012 Biochemical Society© 2012 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
Phosphorylation and regulation of MST3 603
Figure 4 Activation of caspase 3 and cleavage of FLAG–MST3(FL) in
myocytes exposed to daunomycin
Myocytes were uninfected or were infected with AdV–FLAG–MST3(FL) or
AdV–FLAG–MST3(314–431) (to identify the location of the ‘caspase-cleaved’ form
of FLAG-MST3) and (A–C) extracts were prepared. The numbers below the various immunoblot
lanes represent relative band absorbances. (A and B) Myocytes were exposed to 0.5 μM
daunomycin for the times indicated. Extracts were immunoblotted (IB) with antibodies
(Abs) to cleaved (17 kDa) caspase 3 (A), anti-FLAG antibodies (B) or MST3(275–393) (C).
(D) Immunocytochemical localization of FLAG–MST3(FL) or FLAG–MST3(314–431) in
unstimulated [(Di) and (Dii)] myocytes, and in myocytes exposed to calyculin A [100 nM for
10 min; (Diii)] or daunomycin [0.5 μM for 8 h; (Div)]. Experiments were repeated at least twice
with different myocyte preparations with similar results.
calyculin A [Figure 4D(iii)]. We could not detect any nuclear
translocation of cleaved FLAG–MST3 into the nucleus in
myocytes expressing FLAG–MST3(FL) following exposure to
daunomycin [Figure 4D(iv)], presumably because it represents
only a comparatively minor species (Figure 4B). Thus aspects of
the canonical pathway for activation of MST3 operate in cardiac
myocytes, in that MST3 is cleaved during apoptosis (Figure 4B)
and the inactive cleaved form can potentially migrate to the
nucleus [Figure 4D(ii)].
Structural features of MST3 and changes associated with activation
by calyculin A
Since the principal mechanism of activation of MST3 by
calyculin A does not appear to involve caspase cleavage, we
took a computational and biochemical approach to investigate the
structure of MST3. The X-ray structure of the catalytic domain
(residues 1–303) of MST3 has been determined [53,54], but little
is known about the regulatory domain. We first assessed the degree
of disorder of rat MST3 using DISOclust [32]. The initial ∼20
amino acids at the N-terminus constitute a disordered region that
precedes a highly ordered structure (∼270 residues) associated
with the (conserved) kinase catalytic domain (Figure 5A). In
contrast, the regulatory domain [MST3(314–431)] is highly
disordered apart from a relatively low-probability-ordered region
(residues 397–418) towards the C-terminus. Residues 281–
431 were examined using PSIPRED [33]. This detected a
region of low-probability strand structure [W325IFTIR330; note
that this contains MST3(Thr328)] and a helical region between
residues 389 and 421 (Figure 5B) corresponding to the dip
in disorder probability between residues 397 and 418 in
Figure 5(A). A representation of the three-dimensional model
for MST3(FL) using the IntFOLD-TS method [34,35] shows
the disordered N-terminal domain, the ordered catalytic domain
and the largely disordered regulatory domain (Figure 5C). The
strand W325IFTIR330 and the C-terminal predicted helical region
sequences are marked.
Stokes radii (a) of the various FLAG–MST3 species were
determined by gel filtration. The Stokes radius of FLAG–
MST3(FL) by Sephacryl S200HR (Figures 6A and 6B) or
S300HR (Figures 7A, 7C and 7E) chromatography was 47.3–
49.6 Å (where 1 Å = 0.1 nm; Table 1), considerably greater
than the value of 29.2 Å calculated for a globular FLAG–MST3
monomer of ∼49 kDa molecular mass. Either FLAG–MST3(FL)
is highly asymmetric (axial ratio ∼20 for an unhydrated prolate
ellipsoid as calculated from the frictional coefficient [55]) which
could result from the highly disordered structure of its regulatory
domain (Figure 5) or it is complexed with other proteins (including
possibly itself). Using myocytes infected variously with
combinations of FLAG–MST3(FL), HA–MST3(FL) and GST–
MST3(FL) followed by immunoprecipitation or glutathione–
Sepharose precipitation then immunoblotting, we were unable
to find any evidence for homomultimer formation (results not
shown). The Stokes radius of FLAG–MST3(377–431) was
significantly less than that of FLAG–MST3(FL) and, although
still highly asymmetric, was closer to the Stokes radius calculated
for a globular protein (Figures 6A and 6B, and Table 1), suggesting
that the C-terminal MST3(377–431) sequence may be involved
in a heterologous interaction with another protein. As would be
predicted, FLAG–MST3(341–431) and FLAG–MST3(314–
431) also eluted at volumes closer to their calculated Stokes
radii for corresponding globular proteins (Figure 6A and 6B, and
Table 1).
Exposure of myocytes expressing FLAG–MST3(FL) to
calyculin A caused a dramatic reduction in the Stokes radius,
suggesting dissociation of a macromolecular complex involving
FLAG–MST3(FL) or a dramatic shape change (Figures 7A–7C
and 7E, and Table 1). Mixing of FLAG–MST3(FL) extracts
from myocytes exposed or not exposed to calyculin A clearly
showed the separation of inactive FLAG–MST3(FL) (Figure 7C,
lower band) from activated FLAG-MST3(FL) (Figure 7C, upper
band). Furthermore, the Stokes radius of FLAG–MST3(T328A) is
significantly less (P < 0.001) than FLAG–MST3(FL) (Figures 7D
and 7E, and Table 1) and its elution volume was not significantly
altered by exposure of myocytes to calyculin A (Figure 7D),
suggesting that it does not interact with other proteins in the same
manner as FLAG–MST3(FL).
Interaction of MST3 with GOLGA2/gm130 and MO25, and the
function of MST3(Thr328) phosphorylation
YSK1/SOK1 (another member of the GCKIII subgroup)
interacts with the Golgi protein GOLGA2/gm130 [56–59] with
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Figure 5 Modelling of MST3 structure
(A) Disorder probability plot for MST3(FL) produced with the DISOclust method for the prediction of intrinsically unstructured regions in proteins. (B) Graphical view of predicted secondary structure
of MST3(281–431) from the PSIPRED server. (C) Representation of the three-dimensional model for MST3(FL) full-length sequence, produced using the IntFOLD-TS method. Colouring represents
predicted local errors, from blue (high accuracy) through green, yellow and orange to red (low accuracy) using the ModFOLDclust2 model quality assessment method. The intrinsically unstructured
residues that have a high predicted error are shown in red. Residue labelling and the stick representation indicates the WIFTIR sequence and the C-terminal predicted helical region. The image was
rendered using PyMol.
residues 20–302 of YSK1/SOK1 (this represents the entire
catalytic domain) being important in this interaction [56].
Fidalgo et al. [58] have interpreted the data from [56] as
indicating that residues 270–302 are critical in the interaction
of YSK1/SOK1 with GOLGA2/gm130. However, an interaction
between MST3 and GOLGA2/gm130 could not be identified
[56]. This is surprising, given that the residues in rat MST3
{MST3(274–306), which also contain the bipartite NLS [28]} are
homologous to YSK1/SOK1(270–302) (24/33 identity with 4/33
conservative replacements). We examined the interaction between
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Figure 6 Sephacryl S200HR chromatography of FLAG–MST3
Extracts of unstimulated AdV-infected myocytes individually expressing FLAG–MST3(FL), FLAG–MST3(314–431), FLAG–MST3(341–431) and FLAG–MST3(377–431) were combined and
subjected to gel-filtration chromatography using Sephacryl S200HR. (A) Immunoblotting of column fractions with anti-FLAG antibodies. The lowest mobility band is FLAG–MST3(FL) and the
highest is FLAG–MST3(314–431). Lane S is a standard containing combined unfractionated extracts from myocytes expressing the four MST3 species. (B) Elution profile showing quantification
of band intensities., FLAG–MST3(FL);, FLAG–MST3(377–431);, FLAG–MST3(341–431); and, FLAG–MST3(314–431). (C) The Sephacryl S200HR column was standardized with
proteins of known Stokes radii (taken from the literature). 1: IgG, 50.0 A˚; 2: BSA dimer, 47.5 A˚; 3: rabbit muscle phosphorylase b monomer, 37.0 A˚; 4: BSA monomer, 35.0 A˚; 5: ovalbumin, 30.5 A˚;
6: β-lactoglobin, 26.7 A˚; 7: cytochrome c, 17.0 A˚. Experiments were repeated three times with different myocyte preparations with similar results.
FLAG–MST3(FL) and GOLGA2/gm130 in myocytes with and
without calyculin A exposure. GOLGA2/gm130 was detected
in immunoprecipitates of FLAG–MST3(FL) in unstimulated
myocytes indicating an association (Figure 8A). Incubation
of myocytes with calyculin A resulted in a decrease in this
association (Figures 8A and 8B). Interactions (not necessarily
direct and sometimes mediated by GOLGA2/gm130 [58])
between GCKIII members and CCM3/PDCD10, one of the
proteins important in cerebral cavernous malformations [11],
have been demonstrated [12,15,58,60,61]. We therefore also
attempted to detect interactions between FLAG–MST3 and
CCM3/PDCD10, but were unsuccessful (results not shown).
However, further investigation of interactions between MST3
and heterologous proteins is warranted especially in view of
recent work on striatins. Striatins (most abundant in the brain
[62,63] although splice variants are expressed in the heart [64])
are PP2A B-type regulatory subunit scaffolding proteins which
form complexes [STRIPAKs (striatin-interacting phosphatase and
kinases)] with PP2A and additionally contain GCKIII members,
CCM3/PDCD10 and phocein/Mob3 (which is present in the Golgi
and other membranous structures) [15,60,65,66].
MO25 (of which there are two isoforms, MO25α and MO25β)
is an evolutionarily conserved protein first identified by its
expression during early murine embryogenesis [67,68]. It is
best characterized as a scaffolding protein in a heterotrimer
with the STRAD pseudokinases and the LKB1 (liver kinase
B1) tumour suppressor kinase [3]. Binding of STRADα to
MO25 involves four interaction sites (sites A–D) in STRADα:
Glu105 (site A), Ile138 (site B), Tyr185 (site C) and the C-terminal
Trp429–(Glu430)–Phe431 [W(E)F] motif (site D) [69,70]. A recent
analysis of human Ste20-related kinases revealed that all four
sites are conserved in the GCKIII and GCKVI subgroups, with
sites A–C lying in the catalytic domain and site D in the
C-terminal regulatory domain [4]. In rat MST3 (Supplementary
Figure S1), at Glu58, Leu90 and Tyr134 constitute sites A–C
respectively, and the STRADα site DW(E)F motif is replaced
by a WIF motif at residues 325–327, immediately N-terminal
to MST3(Thr328). Surface plasmon resonance showed that
MO25 isoforms (MO25α and MO25β) bind to the two
GCKVI members [OXSR1 (oxidative-stress responsive 1)/
OSR1/KIAA1101 and SPAK (SPS1-related proline-alanine-rich
protein kinase)/PASK/Stk39 (serine threonine kinase 39) and the
GCKIII member MST4/MASK with Kd1 values in the 3–10 μM
range (as opposed to about 10–50 nM with STRADα) [3,4].
MST3 and YSK1/SOK1 were not studied. The activities of the
wild-type GCKIII kinases are stimulated 2–5-fold by MO25α [4].
Stimulation of the activities of the GCKVI members is greater
(70–100-fold), but the threonine residue of their activation loops
had been mutated phosphomimetically to glutamic acid, so the
situation is not necessarily comparable.
Because the sites involved in interaction with MO25
are conserved in all five GCKIII/GCKVI members, we
examined the interaction between MO25 and FLAG–MST3(FL).
Neither MO25α nor MO25β co-immunoprecipitated with
FLAG–MST3(FL) in myocyte extracts in the absence of
exposure to calyculin A (Figure 8C, top and middle
panels). However, following exposure of myocytes to calyculin
A and associated phosphorylation of FLAG–MST3(Thr328)
(Figure 8C, bottom panel)], MO25α and MO25β each co-
immunoprecipitated with FLAG–MST3(FL) (Figure 8C, top and
middle panels). In an analogous experiment with myocytes
expressing FLAG–MST3(FL) or FLAG–MST3(T328A) at
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Table 1 Stokes radii of FLAG–MST3
Stokes radii were measured using calibrated Sephacryl S200HR or S300HR columns (see Figures 6 and 7). Molecular mass (M in Da) was calculated from amino acid sequences. Frictional ratios
(f/f0) were calculated from the formula: f / f o = a /(3vM /4π N )1/3 where a in the Stokes radius, v is the partial specific volume (assumed to be 0.74 ml/g) and N is Avagadro’s number. The
theoretical values of Stokes radii for globular proteins were calculated assuming a value of 1.2 for f/f0 [75]. Axial ratios for prolate, unhydrated ellipsoids of revolution were derived from published
Tables [55].
FLAG–MST3 species M (Da) a (A˚), S300HR a (A˚), S200HR Theoretical monomeric a (A˚) (f/f0) Axial ratio
FLAG–MST3(FL) 48984 49.6 +− 0.6 (8) 47.3 +− 0.3 (3) 29.2 1.95–2.04 19–21
FLAG–MST3(FL) in calyculin A-treated (100 nM, 10 min) myocytes 48984 40.1 +− 0.2 (7) – 29.2 1.65 12
FLAG–MST3(T328A) 48954 39.0 +− 0.7 (3) – 29.2 1.61 11
FLAG–MST3(377–431) 43180 – 35.2 +− 0.6 (3) 28.0 1.51 9.4
FLAG–MST3(341–431) 39089 – 32.9 +− 0.6 (3) 27.1 1.46 8.5
FLAG–MST3(314–431) 36255 – 31.3 +− 0.3 (3) 26.4 1.42 7.8
Figure 7 Sephacryl S300HR chromatography of FLAG–MST3 in myocyte extracts
AdV-infected myocytes expressing (A–C) FLAG–MST3(FL) or (D) FLAG–MST3(T328A) were unstimulated or exposed to calyculin A (100 nM for 10 min) and the extracts were subjected to
gel-filtration chromatography using Sephacryl S300HR. (A–D) Column fractions were immunoblotted with anti-FLAG antibodies: (A) fractions from unstimulated myocytes; (B) fractions from
myocytes exposed to calyculin A; (C) fractions from mixed extracts from unstimulated myocytes and myocytes exposed to calyculin A; and (D) fractions from unstimulated myocytes (left-hand panel)
or myocytes exposed to calyculin A (right-hand panel). In (A), M is a marker lane of FLAG–MST3(FL) in whole myocyte extracts. In (C), M is a marker lane of mixed whole extracts of FLAG–MST3(FL)
from myocytes unexposed or exposed to calyculin A. (E) Elution profiles for the quantified imunoblots. , FLAG–MST3(FL);, FLAG–MST3(FL) from myocytes exposed to calyculin A; and ,
FLAG–MST3(T328A). (F) The Sephacryl S300HR column was standardized with proteins of known Stokes radii (taken from the literature). 1: ferritin, 61.0 A˚; 2: catalase tetramer, 52.0 A˚; 3: IgG, 50.0
A˚; 4: BSA dimer, 47.5 A˚; 5: catalase dimer, 45.0 A˚; 6: BSA monomer, 35.0 A˚; 7: Hb, 31.0 A˚; 8: cytochrome c, 17.0 A˚. Experiments were repeated at least twice with different myocyte preparations with
similar results.
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Table 2 Sequences of the WX(F/W)(S/T)-like sequence in GCKIII and GCKVI subgroups in H. sapiens and mouse
The WX(F/W)(S/T)-like sequence corresponds to site D in STRADα [4]. In Xenopus laevis MST3 (GenBank® acession number NP_001085728), the sequence is W323NFTRR328, and in Danio rerio
MST3 (GenBank® acession number NP_998642), it is W315IFTIR320. It is also conserved in MST3 of many other vertebrates. For the GCKVI subgroup, the STRADα site D-like ‘WEW’ sequence has
been extended on either side to show the acidic nature of the region.
GCK subgroup
GenBank® accession number (H. sapiens), with residue
numbers of the WX(F/W)(S/T)-like sequence in parentheses
GenBank® accession number (mouse), with residue
numbers of the WX(F/W)(S/T)-like sequence in parentheses WX(F/W)(S/T)-like sequence
GCKIII subgroup
MST3 (Stk24) NP_001027467 (325–330) NP_663440 (325–330) WIF–TIR
YSK1/SOK1 (Stk25) NP_006365 (319–326) NP_067512 (319–326) WTFPPTIR
MST4/MASK NP_057626 (324–330) NP_598490 (324–330) WSFT-TVR
GCKVI subgroup
SPAK/PASK (Stk39) NP_037365 (378–395) NP_058562 (390–407) EDGDWEWSDDEMDEKSEE
OXSR1/OSR/KIAA1101 NP_005100 (332–349) NP_598746 (332–349) EDGGWEWSDDEFDEESEE
Figure 8 Co-immunoprecipitation of FLAG–MST3 with GOLGA2/gm130 or MO25
Uninfected or AdV-infected myocytes expressing FLAG–MST3(FL) or FLAG–MST3(T328A) were unstimulated or exposed to calyculin A (100 nM for 10 min) and extracts were prepared.
FLAG–MST3(FL) was immunoprecipitated (IP) with anti-FLAG M2 affinity gel and subjected to immunoblot (IB) analysis. (A) Co-immunoprecipitation of GOLGA2/gm130 with FLAG–MST3(FL).
Inputs (left-hand panels) or immunoprecipitates (right-hand panels) of myocyte extracts were immunoblotted with anti-FLAG antibodies (Abs, upper panels) or antibodies against GOLGA2/gm130
(lower panels). (B) Quantification of GOLGA2/gm130 co-immunoprecipitated with FLAG–MST3(FL). Results are means +− S.E.M. for three separate preparations of myocytes; *P < 0.001 compared
with unstimulated myocytes. (C) Co-immunoprecipitation of MO25α and MO25β with FLAG–MST3(FL). All myocytes were infected with AdV–FLAG–MST3(FL). The two lanes to the left-hand
side show inputs of myocyte extracts with immunoprecipitates in the two lanes to the right-hand side. Extracts were immunoblotted with anti-MO25α mAbs (top panel), or antibodies to MO25β
(middle panel) or FLAG (bottom panel). (D) FLAG–MST3(T328A) does not interact with MO25α. Anti-FLAG M2 affinity gel was used to immunoprecipitate FLAG–MST3 from myocytes expressing
FLAG–MST3(FL) (middle lanes) or myocytes expressing FLAG–MST3(T328A) (right-hand lanes). Control immunoprecipitations from uninfected myocytes are shown in the left lanes. The upper
panel shows FLAG immunoreactivity and the lower panel shows MO25α immunoreactivity in the immunoprecipitates. Experiments were repeated at least twice with different myocyte preparations
with similar results.
approximately equal levels (Figure 8D, upper panel), MO25α
did not co-immunoprecipitate with FLAG–MST3(T328A) to any
significant extent following exposure of myocytes to calyculin
A (Figure 8D, lower panel), indicative of an absolute
requirement for phosphorylation of this site for association. Thus
phosphorylation of MST3(Thr328) leads to decreased association
with GOLGA2/gm130, together with increased association with
MO25.
Filippi et al. [4] were unable to demonstrate co-immuno-
precipitation of MO25 with any GCKIII or GCKVI kinase
and attributed this to the high Kd values for the interactions.
Our co-immunoprecipitation experiments show that calyculin
A-activated FLAG–MST3(FL) does interact with MO25α (and
MO25β) (Figures 8C and 8D), an interaction that does
not occur with calyculin A-activated FLAG–MST3(T328A)
(Figure 8D). Interestingly, the W325IFTIR330 sequence of MST3
corresponding to a low-probability strand region (Figures 5B
and 5C) is conserved in both YSK1/SOK1 (W319TFPPTIR326)
and MST4/MASK (W324SFTTVR330) (Table 2). In the GCKVI
members, where the WIF motif is replaced by WEW motif, the
residue in the + 1 position relative to the C-terminal tryptophan
is a serine which lies in a highly acidic region in these kinases
(Table 2). Although phosphorylation of a serine in the regulatory
domain of SPAK/PASK/Stk39 or OXSR1/OSR1/KIAA1101 has
been identified, the relevant residue lies in the − 14 position
relative to the serine residue of the WEWS motif [71–73]. Given
that all of the GCKIII and GCKVI members except YSK1/SOK1
contain a serine/threonine residue + 1 to the W(I/S/E)(F/W)
motif (and, even in YSK1/SOK1, there is a threonine residue
at + 3), we suggest that the scheme of activation that we are
proposing for MST3 might be more widely applicable to other
GCKIII/VI members. Furthermore, we can speculate that the
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Figure 9 A model of the non-canonical pathway of MST3 regulation
For details, see the Results and Discussion section. N-T, N-terminus; C-T, C-terminus;
N-lobe and C-lobe, lobes of catalytic domain. The numbers associated with the
disordered regulatory domain denote the relevant amino acid residues (Asp313, Gly340
and Lys376) at the C-termini of FLAG–MST3(314–431), FLAG–MST3(341–431) and
FLAG–MST3(377–431) respectively.
relatively low affinity of GCKIII/GCKVI members for MO25 [4]
might be attributable to the serine/threonine residue immediately
C-terminal to the STRADα-like site D being unphosphorylated.
A model for non-canonical regulation of MST3
From our experiments, we have developed the following
model (Figure 9). MST3 is bound to the Golgi apparatus
protein GOLGA2/gm130 [59] in the basal state, probably
through the MST3(377–431) region. GOLGA2/gm130 might
retain MST3 in the cytoplasm which may be why FLAG–
MST3(314–431) (which gel-filtration experiments suggest is
unable to interact with GOLGA2/gm130) constitutively localizes
to the nucleus [Figure 4D(ii)]. Calyculin A activates MST3
by promoting phosphorylation of MST3(Thr178), and this leads
to cis-autophosphorylation of MST3(Thr328) and dissociation of
the MST3–GOLGA2/gm130 complex. The MST3(Thr328) cis-
autophosphorylation requires the ‘docking domain’ encompassed
by MST3 residues 341–376 and does not directly affect MST3
activity. MST3(Thr328) lies within a conserved WIFTIR sequence
that may represent a structured region in the regulatory domain
which is, overall, highly disordered. Cis-autophosphorylation of
MST3(Thr328) simultaneously allows MO25 to bind to MST3.
The function of the MST3–MO25 interaction is unknown as yet.
In the MO25–STRAD–LKB1 complex, the GCKVI homologue
STRAD is involved in nucleocytoplasmic shuttling of LKB1
and the interaction between LKB1 and STRAD (stabilized by
MO25) localizes LKB1 to the cytoplasm [69,74]. It is possible
that the various complexes that MST3 forms are related to the
determination of subcellular localization.
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Figure S1 MST3 alignments in H. sapiens, mouse and rat
GenBank® accession numbers are NP_001027467.2 for H. sapiens 431 residue MST3 [note that this is shown as shown as MST3b on the NCBI database (http://www.ncbi.nlm.nih.gov/protein/)],
NP_003567.2 for H. sapiens 443 residue MST3b (shown as MST3a on the NCBI database) and NP_663440.1 (431 residues) for mouse. The rat sequence was derived from our cDNA sequence,
EU371958.1, but now also see NP_001120966.1 (431 residue MST3), deposited on 14-09-2011. ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/) was used to align the sequences. As
implied, the attributions in the NCBI database are confused. The earliest reference associated with the 443 residue NP_003567.2 entry [1] in fact refers to the 431 residue protein, whereas the earliest
references associated with the NP_001120966.1 entry refer to both the 431 residue [1] and the 443 residue [2] proteins.
1 To who correspondence should be addressed (email p.sugden@reading.ac.uk).
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Figure S2 Exposure of myocytes to calyculin A results in the appearance
of only a single 58 kDa FLAG–MST3 band
Myocytes were infected with AdV–FLAG–MST3(FL). They were either not stimulated or were
exposed to calyculin A (100 nM for 10 min), and extracts were prepared. Proteins were separated
by SDS/PAGE followed by immunoblot analysis with anti-FLAG antibodies. The numbers on the
sides of the immunoblot signify the positions of the molecular-mass markers in kDa.
REFERENCES
1 Schinkmann, K. and Blenis, J. (1997) Cloning and characterization of a human STE20-like
protein kinase with unusual cofactor requirements. J. Biol. Chem. 272, 28695–28703
2 Zhou, T.-H., Ling, K., Guo, J., Zhou, H., Wu, Y.-L., Jing, Q., Ma, L. and Pei, G. (2000)
Identification of a human brain-specific isoform of mammalian STE20-like kinase 3 that is
regulated by cAMP-dependent protein kinase. J. Biol. Chem. 275, 2513–2519
Received 15 November 2011/4 January 2012; accepted 9 January 2012
Published as BJ Immediate Publication 9 January 2012, doi:10.1042/BJ20112000
Figure S3 Alanine scanning of the FLAG–MST3(341–376) and FLAG–
MST3(299–308) regions
Myocytes were infected with the appropriate AdV vectors. They were either unstimulated or
were exposed to calyculin A (100 nM for 10 min), and extracts were prepared. Proteins were
separated by SDS/PAGE followed by immunoblot (IB) analysis with anti-FLAG antibodies.
Immunoblots are representative of experiments repeated at least twice with different myocyte
preparations. Calyculin A-induced reductions in FLAG–MST3(FL) are shown for comparison.
(A) Individual (left-hand panel) mutation of each of the six serine/threonine residues in the
FLAG–MST3(341–376) region or combined mutation of all six serine/threonine residues
(right-hand panel) did not affect the ability of calyculin A to reduce the mobility of FLAG–MST3.
(B) Individual mutation of each of the five serine residues in the FLAG–MST3(299–308) region or
combined mutation of FLAG–MST3(S303/304/305) and FLAG–MST3(S299/303/304/305/308)
did not affect the ability of calyculin A to reduce the mobility of FLAG–MST3.
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